pyrazines has been researched along with Osteoporosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Issaragrisil, S; Kheolamai, P; Klincumhom, N; Manochantr, S; Sanvoranart, T; Supokawej, A; U-Pratya, Y; Wattanapanitch, M | 1 |
| Gao, B; Han, YH; Hu, YQ; Huang, Q; Jie, Q; Liu, BH; Lu, WG; Luo, ZJ; Shi, J; Wang, L; Yang, L; Zhang, HY; Zhao, ZJ | 1 |
| Gryczynski, Z; Ranjan, AP; Raut, SL; Thamake, SI; Vishwanatha, JK | 1 |
| Hess, U | 1 |
| Gaillarde, B; Nove-Josserand, G; Ortonne, JP; Philippe, LP; Plauchu, M; Pugiat, M | 1 |
1 review(s) available for pyrazines and Osteoporosis
| Article | Year |
|---|---|
[The plasma cell myeloma--molecular pathogenesis and target therapies].
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cell Communication; Chromosome Aberrations; Gene Expression; Glycoproteins; Growth Inhibitors; Humans; Immunologic Factors; Immunosuppressive Agents; Lenalidomide; Multiple Myeloma; Osteoporosis; Osteoprotegerin; Oxides; Protease Inhibitors; Pyrazines; Randomized Controlled Trials as Topic; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Thalidomide; Time Factors | 2006 |
4 other study(ies) available for pyrazines and Osteoporosis
| Article | Year |
|---|---|
Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Topics: Adipogenesis; Alkaline Phosphatase; Bone Diseases, Metabolic; Boronic Acids; Bortezomib; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Female; Humans; Integrin-Binding Sialoprotein; Mesenchymal Stem Cells; Osteoblasts; Osteogenesis; Osteoporosis; Placenta; Pregnancy; Pyrazines; Sp7 Transcription Factor; Transcription Factors; Up-Regulation | 2014 |
Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Bone and Bones; Dexamethasone; Glucocorticoids; Mesenchymal Stem Cells; Organ Size; Osteogenesis; Osteoporosis; Protective Agents; Pyrazines; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |
Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Boronic Acids; Bortezomib; Breast Neoplasms; Curcumin; Drug Carriers; Female; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Osteoporosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines | 2012 |
[Value of pyrazinobutazone in the treatment of various inflammatory conditions].
Topics: Anti-Inflammatory Agents; Arthritis; Drug Tolerance; Neuralgia; Osteoarthritis; Osteoporosis; Phenylbutazone; Phlebitis; Pyrazines; Rheumatic Diseases; Spondylitis | 1972 |